July 1, 2015 - Nasdaq (Nasdaq: NDAQ) announced that trading in FIT Biotech Oy shares (short name: FITBIO) commenced today on Nasdaq First North in Helsinki. The company belongs to the Health Care sector. Nasdaq First North is a Multilateral Trading Facility (MTF) aimed towards emerging growth companies and is operated by Nasdaq Nordic exchanges.
FIT Biotech is a biotechnology company founded in 1995 focusing on DNA-vaccines and gene therapy. The company has developed a patented gene transfer technology, GTU®(Gene Transport Unit). The technology is used in developing DNA-vaccines for preventive as well as therapeutic use in diseases such as HIV and tuberculosis. In gene therapy FIT targets cancer as well as autoimmune diseases. Additional fields of use are under active study. For more information, please visit www.fitbiotech.com
”The listing and the funds raised in the initial public offering with the strengthening of the balance sheet through the offering, position the company well to implement its business plan together with a broader shareholder basis. We welcome you to join us in developing Finnish international biotech business,” says Kalevi Reijonen, CEO of FIT Biotech Oy.
“We are excited to welcome FIT Biotech Oy to Nasdaq First North where we today have already 16 companies listed in Finland. The listing of FIT Biotech represents already the 8th listing on Nasdaq Helsinki this year,” said Lauri Rosendahl, President of Nasdaq Helsinki. “FIT Biotech will make a great addition to our Health Care sector, and we look forward to a long-standing partnership with the company and its shareholders.”
Adam Kostyál, Senior Vice President and Head of listings at Nasdaq Nordic said: “We are pleased to see continued strong progress with the listings across our Nordic markets. The listing of FIT Biotech is already the 60th company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.
FIT Biotech Oy has appointed Translink Corporate Finance Oy as its Certified Adviser.
*Main markets and First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately 9.5 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com.
Cautionary Note Regarding Forward-Looking Statements
Information set forth in this communication contains forward-looking statements that involve a number of risks and uncertainties. Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. Such forward-looking statements include, but are not limited to, statements about our capital return initiatives. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq’s control. These factors include, but are not limited to, Nasdaq’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors detailed in Nasdaq’s filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q. Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
FOR MEDIA RELATIONS:
Maarit Bystedt
tel. +358 (0) 6166 7274
maarit.bystedt@nasdaq.com
